Alliance Pharma (GB:APH) has released an update.
Alliance Pharma PLC announces a CEO transition, with Nick Sedgwick replacing outgoing CEO Peter Butterfield on May 13, 2024. Butterfield, who has been with Alliance since 2010 and CEO since 2018, significantly expanded the company’s consumer healthcare focus and global presence. Sedgwick, with a 30-year background in consumer health at major multinationals, is expected to lead Alliance through the next growth phase.
For further insights into GB:APH stock, check out TipRanks’ Stock Analysis page.
